Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,367
Closed -$2.12M 25
2025
Q4
$2.12M Buy
26,367
+12,574
+91% +$1.05M 0.12% 179
2025
Q3
$1.35M Buy
+13,793
New +$1.11M 0.09% 313
2025
Q2
Sell
-4,082
Closed -$203K 1995
2025
Q1
$203K Sell
4,082
-12,727
-76% -$805K 0.02% 988
2024
Q4
$1.17M Buy
16,809
+12,834
+323% +$1.07M 0.16% 195
2024
Q3
$417K Buy
3,975
+1,346
+51% +$157K 0.04% 741
2024
Q2
$374K Buy
2,629
+2,516
+2,227% +$290K 0.05% 562
2024
Q1
$12.6K Sell
113
-1,390
-92% -$166K ﹤0.01% 1065
2023
Q4
$195K Buy
+1,503
New +$207K 0.04% 623

Other funds holding ACLS

AlphaQuest's ACLS Position: Q1 2026 in Review

AlphaQuest sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 26,367 shares — an estimated $2.12M sold.

AlphaQuest first reported a position in ACLS in Q4 2023 and held it in 8 quarters. The position peaked at $2.12M in Q4 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • AlphaQuest reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 26,367 Axcelis shares in Q1 2026, an estimated $2.12M.
  • AlphaQuest first reported a position in Axcelis in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Axcelis position peaked at $2.12M in Q4 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.